We would like to thank our exhibitors and sponsors for sponsoring this meeting. This includes pharmaceutical companies including AstraZeneca UK and Pfizer Ltd. They have had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the sponsored symposia presentations.

Event Schedule

Wednesday, February 11, 2026
9:20 AM - 10:15 AM
Chair’s opening remarks followed by: Eczema management: Assessment, triggers and treatment
  • Identifying eczema patterns, severity and potential triggers during clinical assessments   
  • Managing flares and treating eczema appropriately using emollient and topical corticosteroids  
  • Supporting patients' long term to avoid triggers and find skin care routines they can manage  
 
 
10:25 AM - 11:10 AM
Adopting evidence-based asthma management, case studies and discussion
  • Update – latest national guidelines and treatment options 
  • Patient case study and discussion 
  • Top tips for best practice in asthma care 
This is a promotional symposium sponsored and organised by AstraZeneca and is intended for UK HCPs only.

11:20 AM - 12:05 PM
All you need to know about depression
  • Identifying causes and recognising depression during routine reviews (e.g. long-term condition checks) 
  • Using screening tools, understanding diagnosis and advising self-referral to talking therapies in line with NICE guidance 
  • Recognising depression in older adults and differentiating symptoms from dementia 
  • Overview of antidepressant treatment, monitoring response and awareness of emerging therapies such as tDCS 
 
 
12:15 PM - 1:00 PM
Lifestyle management: Type 2 diabetes and obesity
  • Applying NICE guidance in everyday primary care practice: the role of nurses in lifestyle management 
  • Practical implementation of NICE recommendations within routine consultations and reviews 
  • Using the 3 A’s framework to confidently and sensitively raise obesity in clinical consultations 
  • Signposting, referral pathways and ongoing support for obesity management 
 
 
1:10 PM - 1:55 PM
Transforming COPD care: Preventing hospitalisation with primary care interventions
  • Exacerbations as the driving force of poor outcomes in COPD 
  • COPD burden and the risk of premature mortality  
  • Guidance on COPD pharmacotherapy 
This is a promotional symposium sponsored and organised by AstraZeneca and is intended for UK HCPs only.

2:05 PM - 2:50 PM
High-risk COVID-19 Patients: who are they and how do we find them?
 
This promotional session has been organised and fully funded by Pfizer and is intended for UK Healthcare Professionals only.

3:00 PM - 3:45 PM
Recognising and managing bronchiectasis in practice
  • Identifying key symptoms such as chronic productive cough, recurrent infections and coarse crackles 
  • How to use structured assessments to differentiate from other respiratory conditions 
  • Red flags and risk factors: repeated antibiotic use, unexplained crackles or haemoptysis and understanding when to investigate or refer for specialist input 
 
 

6 CPD hours

Speakers